Injectable Girth Augmentation
HA Filler, PMMA, Silicone, Autologous Fat
Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- No filler is FDA-approved for penile girth; permanent materials discouraged/banned in places
Reference only. Not medical advice.
What can go wrong
HA: nodules, migration, contour irregularity, granuloma with high-cross-linked product. PMMA and silicone: foreign-body granulomas, chronic inflammation, migration, disfigurement, and difficult removal; non-medical 'silicone/mystery gel' injection is especially hazardous. Autologous fat: reabsorption requiring repeat procedures, asymmetry, palpable lumps, fat necrosis, infection, and altered sensation. All carry infection and cosmetic-dissatisfaction risk.
This is something to take to a clinician. The Atlas can tell you what is known about injectable girth augmentation in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Injectable girth augmentation adds volume under the penile skin using hyaluronic acid (HA) filler, polymethylmethacrylate (PMMA), liquid silicone, or the patient's own fat. HA is the most commonly used and comparatively lower-risk option, but it is temporary (resorbs over months) and can migrate or form nodules and granulomas. PMMA and silicone are permanent foreign bodies associated with granulomas and disfigurement, difficult to remove, and banned or discouraged for this use in several jurisdictions. Autologous fat transfer avoids a foreign body but suffers substantial reabsorption (commonly ~10-30% within months), asymmetry, lumps, and necrosis; systematic-review data put fat-transfer complication incidence around 4% or higher depending on site and definition.
Girth by injection: HA is temporary, permanent materials are dangerous, fat is unpredictable.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
All variants work by mechanical volume addition in the subcutaneous/dartos plane, not by growing the penis. HA is a resorbable gel; PMMA suspends permanent microspheres in a carrier; silicone is a permanent liquid; autologous fat transfers living/adipose tissue that must revascularize to survive. Because none integrates as native shaft tissue, the outcome is added bulk that can migrate, lump, or (for fat) partly disappear.
Volume added is not tissue grown
Marketing frames girth injection as 'enhancement,' but it is a foreign body or an unpredictable graft, not new penile tissue. HA looks safest precisely because it resorbs - which also means repeat cost. Permanent materials trade durability for the risk of granulomas, migration, chronic inflammation, and disfigurement that can be very hard to reverse. Fat's fate is decided by revascularization, so results are asymmetric and partly transient.
Safety in detail
This intervention is a surgical/procedural injection with significant physiological effects and requires evaluation and monitoring by a qualified physician. Self-administration or non-medical injection of fillers, silicone, or 'mystery gels' carries documented, sometimes disfiguring health risks.
What people get wrong
Often saidPermanent fillers give permanent, safe results
ActuallyPMMA and silicone are permanent foreign bodies prone to granulomas, migration, and disfigurement, and are difficult to remove - permanence is a liability, not a feature.
Often saidFat transfer uses your own tissue, so it's safe and lasts
ActuallyA large fraction of transferred fat is reabsorbed, and complications include asymmetry, lumps, and necrosis; results are unpredictable and often require revision.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
Injectables are lucrative repeat business: HA and fat both fade, driving return visits, while clinics capture high per-procedure fees in an out-of-pocket market with little oversight. Complications from permanent materials can create a second market for costly removal/revision surgery.
Set against the alternatives
Among injectables, HA is the least bad (reversible-ish, comparatively lower complication rate) but temporary; PMMA and silicone are the most dangerous (permanent, granuloma-prone); autologous fat is the most unpredictable (reabsorption and asymmetry). None is FDA-approved for penile girth, and all are cosmetic, cash-pay procedures.
At a glance
- HA durability
- Temporary; resorbs over months
- Fat reabsorption
- Commonly ~10-30% in first months
- PMMA/silicone
- Permanent foreign body; granuloma risk
- Fat-transfer complication incidence
- ~4%+ (systematic review)
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Injectable Girth Augmentation. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Systematic review/meta-analysis of HA and PLA for penile augmentation2023
HA with standardized low-volume protocols had lower complication rates than PLA/PMMA/silicone, but adverse events (edema, nodules, granuloma) still occur
Case reports of foreign-body granuloma after filler injectionvarious
Granulomatous reactions documented, sometimes months after injection
Systematic review of autologous fat transfer complicationsrecent
Fat transfer associated with roughly a 4%+ complication incidence; migration and reabsorption are recurrent problems